Correlation Between Takeda Pharmaceutical and CanSino Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Takeda Pharmaceutical and CanSino Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Takeda Pharmaceutical and CanSino Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Takeda Pharmaceutical Co and CanSino Biologics, you can compare the effects of market volatilities on Takeda Pharmaceutical and CanSino Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Takeda Pharmaceutical with a short position of CanSino Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Takeda Pharmaceutical and CanSino Biologics.

Diversification Opportunities for Takeda Pharmaceutical and CanSino Biologics

-0.79
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Takeda and CanSino is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical Co and CanSino Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CanSino Biologics and Takeda Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Takeda Pharmaceutical Co are associated (or correlated) with CanSino Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CanSino Biologics has no effect on the direction of Takeda Pharmaceutical i.e., Takeda Pharmaceutical and CanSino Biologics go up and down completely randomly.

Pair Corralation between Takeda Pharmaceutical and CanSino Biologics

Considering the 90-day investment horizon Takeda Pharmaceutical Co is expected to under-perform the CanSino Biologics. But the stock apears to be less risky and, when comparing its historical volatility, Takeda Pharmaceutical Co is 2.12 times less risky than CanSino Biologics. The stock trades about -0.15 of its potential returns per unit of risk. The CanSino Biologics is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest  351.00  in CanSino Biologics on August 24, 2024 and sell it today you would earn a total of  39.00  from holding CanSino Biologics or generate 11.11% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Takeda Pharmaceutical Co  vs.  CanSino Biologics

 Performance 
       Timeline  
Takeda Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Takeda Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.
CanSino Biologics 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in CanSino Biologics are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady fundamental drivers, CanSino Biologics reported solid returns over the last few months and may actually be approaching a breakup point.

Takeda Pharmaceutical and CanSino Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Takeda Pharmaceutical and CanSino Biologics

The main advantage of trading using opposite Takeda Pharmaceutical and CanSino Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Takeda Pharmaceutical position performs unexpectedly, CanSino Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CanSino Biologics will offset losses from the drop in CanSino Biologics' long position.
The idea behind Takeda Pharmaceutical Co and CanSino Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum